tiprankstipranks
Trending News
More News >
Emergent Biosolutions (EBS)
NYSE:EBS
US Market
Advertisement

Emergent Biosolutions (EBS) Ratios

Compare
1,355 Followers

Emergent Biosolutions Ratios

EBS's free cash flow for Q2 2025 was $0.43. For the 2025 fiscal year, EBS's free cash flow was decreased by $ and operating cash flow was
lt;0.01. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
5.76 1.04 0.98 3.40 3.11
Quick Ratio
3.15 0.54 0.70 2.46 2.31
Cash Ratio
1.80 0.17 0.52 1.54 1.62
Solvency Ratio
0.20 -0.54 -0.04 0.26 0.29
Operating Cash Flow Ratio
0.10 -0.32 -0.03 0.86 1.39
Short-Term Operating Cash Flow Coverage
0.00 -0.50 -0.04 10.16 15.86
Net Current Asset Value
$ -91.60M$ -494.40M$ -572.90M$ -67.90M$ -240.30M
Leverage Ratios
Debt-to-Assets Ratio
0.45 0.47 0.44 0.28 0.30
Debt-to-Equity Ratio
1.14 1.32 1.02 0.52 0.60
Debt-to-Capital Ratio
0.53 0.57 0.50 0.34 0.38
Long-Term Debt-to-Capital Ratio
0.53 0.41 0.24 0.33 0.37
Financial Leverage Ratio
2.51 2.81 2.29 1.83 1.99
Debt Service Coverage Ratio
3.13 -1.07 -0.04 5.67 6.86
Interest Coverage Ratio
1.99 -8.26 -4.45 10.22 13.86
Debt to Market Cap
1.21 7.00 2.38 0.36 0.19
Interest Debt Per Share
13.58 18.52 28.80 16.36 17.19
Net Debt to EBITDA
1.93 -1.48 -23.20 0.58 0.46
Profitability Margins
Gross Profit Margin
57.80%32.77%38.11%57.75%66.31%
EBIT Margin
15.13%-61.31%-16.21%18.51%27.94%
EBITDA Margin
27.37%-48.16%-2.94%25.56%35.30%
Operating Profit Margin
15.02%-69.23%-14.81%19.67%27.89%
Pretax Profit Margin
13.42%-69.68%-19.78%17.54%26.18%
Net Profit Margin
9.62%-72.48%-19.97%12.24%19.66%
Continuous Operations Profit Margin
9.62%-72.48%-18.88%12.24%19.62%
Net Income Per EBT
71.67%104.01%100.95%69.82%75.10%
EBT Per EBIT
89.37%100.66%133.55%89.17%93.87%
Return on Assets (ROA)
5.20%-41.71%-7.07%7.42%10.61%
Return on Equity (ROE)
14.09%-117.13%-16.18%13.56%21.13%
Return on Capital Employed (ROCE)
8.95%-61.98%-8.57%13.64%17.36%
Return on Invested Capital (ROIC)
6.41%-47.65%-5.79%9.90%12.83%
Return on Tangible Assets
7.53%-60.52%-10.08%10.31%15.65%
Earnings Yield
14.04%-618.90%-37.82%9.44%6.48%
Efficiency Ratios
Receivables Turnover
5.28 5.49 7.04 6.43 6.74
Payables Turnover
5.80 6.29 6.70 5.88 3.85
Inventory Turnover
0.93 2.14 1.97 2.16 1.71
Fixed Asset Turnover
3.76 2.63 1.37 2.24 2.41
Asset Turnover
0.54 0.58 0.35 0.61 0.54
Working Capital Turnover Ratio
1.27 233.18 2.55 2.10 2.43
Cash Conversion Cycle
396.89 178.57 182.49 163.71 173.23
Days of Sales Outstanding
69.17 66.44 51.84 56.79 54.18
Days of Inventory Outstanding
390.66 170.19 185.10 169.03 213.85
Days of Payables Outstanding
62.93 58.06 54.46 62.11 94.80
Operating Cycle
459.83 236.62 236.94 225.82 268.03
Cash Flow Ratios
Operating Cash Flow Per Share
0.24 -4.03 -0.68 6.00 10.17
Free Cash Flow Per Share
0.03 -5.04 -2.99 1.80 7.50
CapEx Per Share
0.22 1.01 2.31 4.21 2.68
Free Cash Flow to Operating Cash Flow
0.11 1.25 4.40 0.30 0.74
Dividend Paid and CapEx Coverage Ratio
1.12 -4.00 -0.29 1.43 3.80
Capital Expenditure Coverage Ratio
1.12 -4.00 -0.29 1.43 3.80
Operating Cash Flow Coverage Ratio
0.02 -0.24 -0.02 0.38 0.61
Operating Cash Flow to Sales Ratio
0.02 -0.20 -0.03 0.18 0.34
Free Cash Flow Yield
0.26%-209.88%-25.33%4.13%8.37%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
7.12 -0.16 -2.64 10.60 15.44
Price-to-Sales (P/S) Ratio
0.70 0.12 0.53 1.30 3.04
Price-to-Book (P/B) Ratio
0.93 0.19 0.43 1.44 3.26
Price-to-Free Cash Flow (P/FCF) Ratio
391.70 -0.48 -3.95 24.20 11.95
Price-to-Operating Cash Flow Ratio
41.58 -0.60 -17.35 7.24 8.81
Price-to-Earnings Growth (PEG) Ratio
-0.15 >-0.01 0.01 -0.36 0.03
Price-to-Fair Value
0.93 0.19 0.43 1.44 3.26
Enterprise Value Multiple
4.47 -1.72 -41.18 5.65 9.06
Enterprise Value
965.99M 871.38M 1.35B 2.59B 4.98B
EV to EBITDA
4.47 -1.72 -41.18 5.65 9.06
EV to Sales
1.22 0.83 1.21 1.45 3.20
EV to Free Cash Flow
689.99 -3.38 -9.04 26.96 12.60
EV to Operating Cash Flow
74.31 -4.22 -39.73 8.07 9.28
Tangible Book Value Per Share
2.44 1.62 8.70 14.76 9.81
Shareholders’ Equity Per Share
10.95 12.68 27.60 30.26 27.46
Tax and Other Ratios
Effective Tax Rate
0.28 -0.04 >-0.01 0.27 0.25
Revenue Per Share
14.83 20.49 22.37 33.51 29.51
Net Income Per Share
1.43 -14.85 -4.47 4.10 5.80
Tax Burden
0.72 1.04 1.01 0.70 0.75
Interest Burden
0.89 1.14 1.22 0.95 0.94
Research & Development to Revenue
0.06 0.11 0.17 0.13 0.15
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.02 0.02 0.04 0.02 0.03
Income Quality
0.17 0.27 0.15 1.39 1.76
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis